000164171 001__ 164171
000164171 005__ 20251127172930.0
000164171 0247_ $$2doi$$a10.1007/s00520-025-10139-y
000164171 0248_ $$2sideral$$a146359
000164171 037__ $$aART-2025-146359
000164171 041__ $$aeng
000164171 100__ $$aAndreu, Yolanda
000164171 245__ $$aHealth-related quality of life in cancer survivors aged 65 and older: impact of diagnosis and treatment and perceived decline associated with aging
000164171 260__ $$c2025
000164171 5060_ $$aAccess copy available to the general public$$fUnrestricted
000164171 5203_ $$aPurpose The health-related quality of life (HRQOL) among older adult cancer survivors can be influenced by physiological and psychosocial challenges stemming from treatment and disease experience. Despite assumptions that aging might exacerbate these difficulties, research indicates higher HRQOL in this subgroup compared to younger adult cancer survivors.
Objectives: (i) to analyze HRQOL in this subgroup, contrasting with younger survivors and (ii) to explore potential moderating factors related to sociodemographic and disease variables.
Method: A cross-sectional study was conducted involving 655 Spanish cancer survivors aged 65 or older from several medical centers and cancer patients’ associations. HRQOL was assessed using the Quality of Life in Adult Cancer Survivors (QLACS) scale. Participants’ data was compared with data from younger survivors (N = 772) [8]. Two Multivariate Variance
Analyses (MANOVA) were performed to address the study objectives.
Results: Older adult survivors exhibited superior HRQOL across all explored domains (except family distress) compared to younger survivors. Predictors of HRQOL included age, primary cancer treatment, and time post-primary treatment. A significant interaction was noted between age and marital status.
Conclusions: The observed higher HRQOL among older adult cancer survivors, particularly in domains seemingly unaffected by cancer, warrants cautious interpretation compared to their younger counterparts. In certain domains, the decline associated
with aging might obscure or impede the perception of the true impact of cancer diagnosis and treatment.
000164171 536__ $$9info:eu-repo/grantAgreement/ES/MINECO/PSI2013-45905-R
000164171 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttps://creativecommons.org/licenses/by/4.0/deed.es
000164171 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000164171 700__ $$0(orcid)0000-0001-9537-3181$$aPicazo, Carmen$$uUniversidad de Zaragoza
000164171 700__ $$aSoto-Rubio, Ana
000164171 700__ $$aGil-Julia, Beatriz
000164171 7102_ $$14009$$2740$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicología Social
000164171 773__ $$g33, 12 (2025), 1069 [8 pp.]$$pSupport. care cancer$$tSUPPORTIVE CARE IN CANCER$$x0941-4355
000164171 8564_ $$s780241$$uhttps://zaguan.unizar.es/record/164171/files/texto_completo.pdf$$yVersión publicada
000164171 8564_ $$s2175722$$uhttps://zaguan.unizar.es/record/164171/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000164171 909CO $$ooai:zaguan.unizar.es:164171$$particulos$$pdriver
000164171 951__ $$a2025-11-27-15:16:24
000164171 980__ $$aARTICLE